Companies: 10,795·Total market cap: $144.5T

SELLAS Life Sciences Group, Inc.

SELLAS Life Sciences Group, Inc.

SLSNASDAQHealthcare● Active

$7.98

$-0.25(-3.04%)

Market Cap$1.1B

P/E Ratio—

52W High$9.51

52W Low$1.39

Avg Volume7.9M

Open$8.51

Beta2.53

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

SELLAS Life Sciences Group, Inc.（SLS）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · SLS · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.23Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding109.1MShares outstanding history

Next EarningsAug 11, 2026Est.Earnings history

探索 SELLAS Life Sciences Group, Inc. 数据

分析师预测$3 · Buy

股息不分红

盈利EPS $-0.25+50.00%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$26.9M▲ +13.01% YoY

202320242025

FY 2025EPS$-0.25▲ +50.00% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$29.5MEPS: $-0.23View income statement →

分析师评级与目标价

Buy5 位分析师

Strong Buy

0

Buy

5

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$2.40Low

$7.98Current

$2.80Avg Target下行风险 64.91%

$3.20High

合计: 5 · 买入占比: 100.0%

根据过去 3 个月内 5 位华尔街分析师，SLS 共识评级为 Buy，12 个月平均目标价 $2.80 （较现价 $7.98 下行风险 64.91%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

SELLAS Life Sciences Group, Inc.

$7.98-3.04%$1.1B #2

Armata Pharmaceuticals, Inc.

$7.57+0.93%$277.9M #3

C4 Therapeutics, Inc.

$3.59-6.75%$297.3M #4

$2.61+1.76%$236.8M #5

$8.95+4.07%$445.7M #6

$1.02-0.97%$135.4M

股票表现

1D-3.04%

1W-0.25%

1M+59.28%

3M+33.89%

YTD+111.67%

1Y+408.28%

5Y-28.30%

关于 SELLAS Life Sciences Group, Inc.

CEOAngelos Stergiou

IPO DateMar 12, 2008

Employees15

CountryUS

Websitesellaslifesciences.com

SELLAS Life Sciences Group, Inc. operates as a late-stage biopharmaceutical entity, dedicated to advancing novel cancer immunotherapies for various cancer indications across the United States. Its pri…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

SELLAS Life Sciences Group, Inc.（SLS）是 Biotechnology 行业的 Healthcare 类公司，于 Mar 12, 2008 在 NASDAQ 上市。截至最近交易日，SLS 股价为 $7.98，市值约为 $1.1B。过去12个月累计回报 +408.28%，年初至今回报 +111.67%。

根据 5 位华尔街分析师，SELLAS Life Sciences Group, Inc. 股票共识评级为Buy，12个月平均目标价为 $2.80。2025 财年 SELLAS Life Sciences Group, Inc. 营收 —，净利润 -$26.9M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，SELLAS Life Sciences Group, Inc.（SLS）股价为 $7.98，在 NASDAQ 上市，52周区间为 $1.39 – $9.51。

SLS 最新股价SLS quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议